<DOC>
	<DOC>NCT01677325</DOC>
	<brief_summary>To investigate in subjects with non-alcoholic fatty liver disease the direct effects of a Chinese herb formula.</brief_summary>
	<brief_title>The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine</brief_title>
	<detailed_description>1) Liver fat (measured by CT scan) and liver function assessed by liver enzymes levels; 2) Insulin sensitivity measured by HOMA index, oral glucose tolerance test (OGTT) and a euglycaemic hyperinsulinaemic clamp (with stable isotopes) in a subset of the subjects; 3) Plasma lipid profile and non esterified fatty acids (NEFA) concentration; 4) Circulating levels of adipokines.</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>subjects with NAFLD(nonalcoholic fatty liver disease) (criteria of Society of Hepatology, Chinese Medical Association, 2002.10), aged 1865 alcohol consumption less than 40g/week; liver/spleen (L/S) ratio no more than 1 by CT scan. ALT more than twice the upper end of the normal range viral hepatitis total parenteral alimentation or secondary liver disease such as hepatocirrhosis, autoimmune hepatitis, metabolic liver disease or drug induced liver disease severe cardiovascular or renal dysfunction Subjects with diabetes (fasting glucose more than or equal to 7.0mmol/L or postprandial glucose more than or equal to 11.1mmol/L) Subjects treated with statins</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>